# Sources — Hatshepsut

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 6, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Dorman PF. "Hatshepsut: Wicked Stepmother or Joan of Arc?" *Oriental Institute News and Notes* 168 (Winter 2001), University of Chicago (Fathom Archive). Supports that she was a daughter of Tuthmose I, to whom she looked as the source of her kingship; that she had been chief queen of Tuthmose II; that she was "ward and regent for her young nephew", whose stepmother she also was; that by year 7 of Tuthmose III she had adopted the public guise of a king while still referred to with feminine forms; that she died in his twenty-second regnal year; that her mother, Queen Ahmose, is named in the divine-birth reliefs; and that the effacing and recarving of her monuments began no earlier than his year 42. https://fathom.lib.uchicago.edu/1/777777190131/
2. The Metropolitan Museum of Art. Collection record for the Seated Statue of Hatshepsut (and other Hatshepsut objects), read through the museum's Collection API: "ca. 1473–1458 BCE", "Joint reign of Hatshepsut and Thutmose III", Dynasty 18, New Kingdom. https://www.metmuseum.org/art/collection/search/544450
3. The British Museum. *Egypt and Sudan Newsletter* 1 (2014), on the exhibition *Pharaoh: King of Egypt*: "the female pharaoh Hatshepsut (1479–1457 BC), who claimed to be born of a secret liaison between her mother and the god" Amun-Ra. https://www.britishmuseum.org/sites/default/files/2020-06/British-Museum_Egypt_Sudan_Newsletter1_2014.pdf
4. Rose M. "Hatshepsut Found; Thutmose I Lost." *Archaeology* (Archaeological Institute of America), July 15, 2007. Reports the 2007 announcement that KV60A is Hatshepsut; the evidence (CT scans, skull type, arm position, quality of mummification, age, and a molar from the chest bearing her name in the DB320 cache that fits a gap in KV60A's jaw where a single root remains, with nearly identical tooth density); the reported findings (about 50 years old, about five feet tall and greatly overweight, massive dental problems with a burst abscess suggested as a cause of death, bone eroded at root tips by infection, severe gum disease, osteoarthritis and osteoporosis, a tumour); the radiologist Ashraf Selim's reading of the left iliac lesion as "a metastatic deposit rather than a primary tumor"; his remark that diabetes is "just a theory based on this circumstantial evidence, which we cannot confirm"; and the caveats: the link between the mummies and the chest "is not without doubt", "the consensus is that the tooth likely broke post mortem", and the DNA work was preliminary. https://archive.archaeology.org/online/features/hatshepsut/
5. Habicht ME, Bouwman AS, Rühli FJ. "Identifications of ancient Egyptian royal mummies from the 18th Dynasty reconsidered." *Am J Phys Anthropol* 2016;159(Suppl 61):S216-S231 (PMID 26808107). Abstract read: not all identifications of New Kingdom royal mummies are clear even now; some remain highly controversial. https://pubmed.ncbi.nlm.nih.gov/26808107/
6. University of Bonn. "Deadly medication?" Press release, August 19, 2011 (EurekAlert!). Supports that a flask in the university's Egyptian Museum bearing her name held the dried residue of a skin lotion or medication, not perfume (palm oil, nutmeg apple oil, unsaturated fatty acids and hydrocarbons from creosote and asphalt), including benzo(a)pyrene, "one of the most dangerous carcinogenic substances we know", and the researchers' suggestion that "she may have exposed herself to a great risk over the years". https://www.eurekalert.org/news-releases/664630
7. HISTMED Master Roster v3. Internal project source; not treated as independent corroboration.

## Clinical guidance

1. American Diabetes Association. *Standards of Care in Diabetes—2026*: Section 2, Diagnosis and Classification (*Diabetes Care* 2026;49(Suppl 1):S27-S49, PMID 41358893), with diagnosis by two abnormal results, which may come from the same sample; Section 8, Obesity and Weight Management (S166-S182, PMID 41358882); Section 9, Pharmacologic Approaches to Glycemic Treatment (S183-S215, PMID 41358900), with GLP-1 receptor agonists favoured when weight is a goal and SGLT2 inhibitors for kidney disease, heart failure or cardiovascular disease; Section 10, Cardiovascular Disease and Risk Management (S216-S245, PMID 41358899), with a moderate-intensity statin for adults 40 to 75 with diabetes. https://pubmed.ncbi.nlm.nih.gov/41358900/
2. Lockhart PB, et al. Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intraoral swelling (American Dental Association). *J Am Dent Assoc* 2019;150(11):906-921 (PMID 31668170): no antibiotics for a localized acute apical abscess when definitive treatment is available; antibiotics as an adjunct only with systemic involvement or spread. https://pubmed.ncbi.nlm.nih.gov/31668170/
3. Carrasco-Labra A, et al. Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain (American Dental Association). *J Am Dent Assoc* 2024;155(2):102-117 (PMID 38325969): an NSAID with acetaminophen first; opioids avoided. https://pubmed.ncbi.nlm.nih.gov/38325969/
4. Sanz M, et al. Scientific evidence on the links between periodontal diseases and diabetes (EFP and IDF consensus). *J Clin Periodontol* 2018;45(2):138-149 (PMID 29280174). https://pubmed.ncbi.nlm.nih.gov/29280174/
5. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis. *J Periodontol* 2018;89(Suppl 1):S159-S172 (PMID 29926952): diabetes with an A1c of 7.0% or more as a grade C modifier. https://pubmed.ncbi.nlm.nih.gov/29926952/
6. Kolasinski SL, et al. 2019 ACR/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. *Arthritis Care Res* 2020;72(2):149-162 (PMID 31908149). https://pubmed.ncbi.nlm.nih.gov/31908149/
7. Gupta K, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women (IDSA and ESCMID). *Clin Infect Dis* 2011;52(5):e103-e120 (PMID 21292654). https://pubmed.ncbi.nlm.nih.gov/21292654/
8. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), diabetes type 2 monograph (A1c every three months until at goal, UACR and eGFR, foot and eye examinations at diagnosis and yearly, a lipid panel 4 to 12 weeks after a statin, PHQ and diabetes distress screening at least yearly, DSMES at diagnosis, dental examination), the rheumatoid arthritis and osteoarthritis monograph, and the hyperlipidemia monograph. The CMID has no dental monograph. https://patrickrutledge.github.io/topthirty/
9. U.S. Preventive Services Task Force A and B recommendations and topic recommendations (depression 2023, unhealthy alcohol use 2018, breast cancer 2024, cervical cancer 2018, colorectal cancer 2021, intimate partner violence 2025, hepatitis C 2020, HIV 2019); CDC hepatitis B screening (2023; PMID 36893044) and the Adult Immunization Schedule by Age; Medicare Preventive Services reference (Aether Forge, 2026). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations

## Editorial resolutions

- **Recent-death rule.** She died about 1458 BC, so the rule does not apply. Claims are limited to what the fetched sources state.
- **How little is knowable (thin chart).** Nothing about her health was written down in her lifetime in any source fetched for this record. Everything medical comes from CT scans of a mummy, KV60A, announced as hers in 2007, and from a lotion flask bearing her name. The identification is debated (CLM-0008), the findings were reported by a learned society's magazine and a documentary fact sheet rather than in a peer-reviewed paper, and even an accepted identification would show only the state of a body at death, read more than three thousand years later. Every finding on the mummy (obesity, the dental abscess and missing teeth, osteoarthritis, osteoporosis, the bone lesion read as a metastasis, the proposed diabetes) and the lotion hypothesis are therefore graded **R**. Her past medical history and family history are empty because nothing is documented. The history is not padded.
- **Dates (correction to the brief).** The brief gives her reign as about 1479 to 1458 BC. The sources support a regency from about 1479 BC, when Thutmose III came to the throne, and kingship from about his year 7: the Metropolitan Museum of Art dates objects of the joint reign to about 1473 to 1458 BCE, and the British Museum gives 1479 to 1457 BC. The record treats 1479 BC as the start of the regency, about 1473 BC as the start of her kingship, and her death as about 1458 BC (Thutmose III's year 22), all approximate. Historical dates use signed astronomical years (-1506 for 1507 BC, -1457 for 1458 BC), with calendar "unknown" and precision "approximate".
- **Birth year (judgment call).** No fetched source records her birth year. The roster's 1507 BC is kept as a very uncertain estimate (-1506, approximate), back-calculated from an age of about 50 suggested for KV60A, and graded **R**, possible (CLM-0005).
- **Index age and dates; no true-date variant.** The synthetic date of birth is February 10, 1978 (her birth month and day are unknown), shift 3484 years. The index visit on April 14, 2026 falls at age 48, which maps to about 1459 BC, late in her reign at Thebes and about a year before her death. Because she was born before 1 CE, the record has no true-date variant (docs/date-shifting.md); the build skips it and the review page says why.
- **Claims after the index date.** The 2007 identification, the CT findings, the lotion flask, her death and the later effacing of her monuments are linked only to timeline events after the index date, so the intake documents do not show them. No modern problem is linked to a claim about the mummy: the presenting jaw swelling, the diabetes, the obesity and the knee osteoarthritis echo the reported findings without claiming them.
- **Name (judgment call).** She is known by a single name. The record uses identity.name_parts with an empty given array and "Hatshepsut" as the family element (family_first false), as other single-name records do, so that generated documents carry the name she is known by. No alias is recorded; her throne name and the title "king" are not used as aliases. The notes call her Ms. Hatshepsut.
- **Culture.** Ancient Egyptian kingship, religion and the divine-birth claim are described plainly from museum and university sources. The modern frame makes her the director of a large public authority for building works and trade missions, the modern counterpart of her documented rule, without costume or exotic detail.
- **Antibiotics withheld (judgment call).** The abscess was localized, with a temperature of 37.6 °C, no trismus and no fascial-space spread, and drainage with extraction was available within 24 hours, so no antibiotic was given, as the ADA 2019 guideline advises. Her new diabetes raised the risk of spread, which the record handles with explicit warning signs and review the next day rather than with an antibiotic.
- **Diabetes diagnosis and treatment (judgment call).** An A1c of 7.6% with a glucose of 212 mg/dL from the same sample confirms diabetes (ADA 2026, two abnormal results). Metformin is started at intake; semaglutide is added at six weeks, after the infection, chosen with her for glucose and weight; an SGLT2 inhibitor is not indicated without kidney disease, heart failure or cardiovascular disease; a moderate-intensity statin is started as the Standards advise for adults 40 to 75 with diabetes. Endocrinology is kept in the plan only if the A1c is not at goal by six months; it was at goal at fourteen weeks.
- **Weight without stigma.** Weight is recorded and discussed only with her permission, in person-first language; her goal is strength and easier stairs, not a number.
- **No bone cancer workup (judgment call).** The proposed metastatic lesion on the mummy is history only. Nothing in the modern episode (no bone pain beyond the knees, no bone tenderness, normal calcium and alkaline phosphatase, only intended weight loss) gives a reason to look for bone cancer, so none is sought. Bone density testing is not indicated at 48 without a risk factor; bone health is addressed through exercise, calcium and vitamin D, with attention to bone and muscle during weight loss on semaglutide.
- **Lotion and carcinogen.** The Bonn hypothesis (CLM-0012) is recorded as **R**; the modern episode does not invent a skin disease or a carcinogen exposure.
- **Sources not used.** The Metropolitan Museum of Art essays and exhibition pages returned rate-limit errors and were read only through collection records; the Smithsonian and Brooklyn Museum pages refused access; no peer-reviewed publication of the KV60A CT findings, and no fetched critique beyond the Archaeology report and the 2016 review abstract, was found. The University of Bonn's own page was read through EurekAlert. Reports that some Egyptologists doubted the flask's authenticity were seen only in secondary coverage and are not claimed.
- **Real people.** Thutmose I, Thutmose II, Thutmose III, Queen Ahmose, Zahi Hawass, Howard Carter, Ashraf Selim and the modern authors appear only in claims and sources. No modern decision, statement or health fact is attributed to any of them; her household is described only as household staff and an adult child.
- **Synthetic content.** All visits, laboratory values, vital signs, dental imaging and findings, the procedures, survey scores, medicines and doses, her height (160 cm) and weights, her work, diet and habits, and the health care agent are synthetic. Qualitative results (urine dipstick and culture, HPV, fecal immunochemical, HIV and hepatitis tests, mammography) appear only in the note text.
- **Sick visit.** Acute uncomplicated cystitis ten weeks after diabetes was found, chosen because urinary infection is common in women with diabetes and tests the plan: a culture because of the diabetes, nitrofurantoin for five days, metformin sick-day rules, and the semaglutide step delayed one week so that nausea is not confused with illness. It implies no real diagnosis.
- **Preventive visit.** A periodic adult preventive visit at 48 (CPT 99396 with 99497 in plain text). Judgment calls: PCV20 for diabetes; Tdap; hepatitis B vaccination for an adult with diabetes under 60, with the second dose at a nurse visit four weeks later (after the record ends); HIV, hepatitis B and C screening; primary HPV testing; mammography and a fecal immunochemical test ordered (both negative); intimate partner violence screening; zoster vaccine from 50; advance care planning limited to her own general preferences.
- **Focused visits.** The three chronic-care follow-ups (the day after intake with the consultation, six weeks, fourteen weeks) are documented as focused visits on the ADA Standards of Care 2026 with the CMID diabetes, osteoarthritis and hyperlipidemia monographs, the ADA 2019 dental antibiotic and 2024 dental pain guidelines, the EFP/IDF 2018 consensus, the 2018 periodontitis staging framework and the ACR 2019 osteoarthritis guideline. One deviation is recorded instead of an invented result: the diabetes distress screen that the CMID monograph calls for at diagnosis was never done; no harm was judged likely from her low PHQ-9 and GAD-7 scores, and it is added to the next visit and to the diabetes visit template. The foot and eye examinations, planned for six weeks so that the dental infection could be treated first, were done then.
- **Consultation.** The oral and maxillofacial surgery referral and the consultation by Rashid Lindqvist-Bello, DDS (a fictional consultant), on the day after intake, are **S**. The consultant answers the five referral questions in line with what the record shows afterwards: a localized acute apical abscess of a non-restorable molar, drained and extracted that day; no antibiotic; stage III, grade C periodontitis with scaling and root planing about eight weeks later and maintenance every three months; the two-way link between periodontitis and diabetes; and follow-up of the socket, which healed by six weeks.
